• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research and Markets: Report Offers Strategic Analysis of the Paediatric and Adolescent Vaccines Market Across the Seven Major Markets and of Key Companies in the Sector

Posted on: Wednesday, 15 August 2007, 09:12 CDT

Research and Markets (http://www.researchandmarkets.com/reports/c65812) has announced the addition of "Pipeline and Commercial Insight: Paediatric and Adolescent Vaccines" to their offering.

The paediatric and adolescent vaccines market encompasses many different classes. DTP and MMR combinations continue to form the mainstay of childhood immunization; however, their growth potential is limited. The key opportunities lie in novel, innovative additions to established schedules, particularly pneumococcal (Prevnar), conjugated meningococcal (Menactra) and HPV (Gardasil) vaccines.

Scope of this title:

-Strategic analysis of the paediatric and adolescent vaccines market across the seven major markets and of key companies in the sector

-Thorough assessment of underlying commercial and clinical influencers shaping the paediatric and adolescent vaccines market

-Patient-based forecasts for key vaccine classes and products according to recommended vaccination groups and coverage rates in the seven major markets

-In-depth discussion of novel vaccine pipeline candidates and discussion of their future potential

Highlights of this title:

Driven by the launch of novel, high-price vaccines such as Gardasil or RotaTeq, the paediatric and adolescent vaccines market is experiencing a rapid growth. Wyeths Prevnar has emerged as the first blockbuster vaccine, demonstrating that innovative vaccines can command high prices and yield high revenues in the paediatric vaccines market. The main future opportunities lie in the pneumococcal, meningococcal and HPV vaccine sectors, where there is a large medical need. Particularly a vaccine against infections with N. meningitidis B would have a potentially huge commercial. Key challenges include the reluctance of healthcare providers to pay for increasingly expensive vaccines and the lack of widespread organized vaccination programs for school children and teenagers. With an increasing focus on adolescent vaccines such as Gardasil or Menactra, better ways to reach adolescents for vaccination will have to be found.

Reasons to order your copy:

-Review clinical and commercial factors driving new product decisions and the strategies of key players in the paediatric and adolescent vaccines market

-Gain insight through a patient-based forecast and a thorough analysis of marketed and pipeline products as well as case studies in key vaccine classes

-Understand concerns, unmet needs and future opportunities by learning about the views of key paediatric and adolescent vaccine opinion leaders

Contents:

About Us

About the Infectious Diseases pharmaceutical analysis team

Chapter 1.

Executive summary

Chapter 2.

Market definition and overview

Chapter 3.

Diphtheria, tetanus, pertussis vaccines - multivalent combinations on the rise

Chapter 4.

Measles, mumps, rubella, varicella vaccines - mmr-v combinations gain popularity

Chapter 5.

Pneumococcal vaccines - prevnar continues to dominate the field

Chapter 6.

Meningococcal vaccines - menactras monopoly under threat

Chapter 7.

Human papillomavirus vaccines - a promising new market

Chapter 8.

Rotavirus vaccines - rotateq and rotarix head-to-head

List of Tables

List of Figures

For more information visit http://www.researchandmarkets.com/reports/c65812.

Source: Datamonitor

Source: Business Wire

More News in this Category